Physician profile
Brian Wolff
NPI 1225089048
$1,252.98
in general payments reported to CMS, 2019-2025
11 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2021: $457 · 2022: $51.88 · 2023: $153 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $218.84 | 2021-2023 | Austedo |
| Ucb, INC. | $166.92 | 2023-2025 | Rystiggo, Nayzilam |
| Livanova USA, INC. | $140.89 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $132.60 | 2021 | |
| Genzyme Corporation | $120.65 | 2019 | |
| Greenwich Biosciences, INC. | $120.56 | 2019 | |
| Abbvie INC. | $118.50 | 2021 | |
| Abbott Laboratories | $97.90 | 2021 | |
| Supernus Pharmaceuticals, INC. | $65.57 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $51.88 | 2022 | |
| Assertio Therapeutics, INC. | $18.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Wolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.